Delivery Order SPE2DR25D3004-SPE2DR26FXTF9
- Not listed
- The Defense Logistics Agency awarded a $1,981.11 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This firm fixed-price contract, which must be completed by July 30, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a $2,107.38 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (20 units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 27, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the company's role as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,056.72 to AmerisourceBergen Drug Corp for Amoxicillin-Clavulanate 875-125 mg tablets (100 count) on August 14, 2025, with a completion date of August 15, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20 units, with a ceiling value of $3,332.36 and an ultimate completion date of January 8, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for AMOXICILLIN-CLAVULANATE 875-125 mg tablets (20-count packages) under a firm fixed-price contract valued at $1,624.54. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $2,462.61 to AmerisourceBergen Drug Corp for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20 on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,146.95 to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (100 count). This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 18, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Amoxicillin-Clavulanate 250-125 mg tablets (30-count packages) with a ceiling value of $1,498.72. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 25, 2025....
- The Defense Logistics Agency awarded a $2,092.43 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This competitively awarded, firm fixed-price delivery order is set to be completed by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical procurement typical of routine medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $7,435.00 for the supply of Amoxicillin 500 mg tablets (100 count). This competitively awarded, non-set-aside contract is classified as a firm fixed-price delivery order with a completion date of December 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXTF9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,688.59 to AmerisourceBergen Drug Corp for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (100-count) with a completion date of January 9, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order falls within AmerisourceBergen's comprehensive $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical that extends through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds an even larger IDC valued at $999,999,999 through December 2031, underscoring the company's role as a critical vendor for federal pharmaceutical and medical supply distribution. The antibiotic product being delivered supports military treatment facilities and veteran healthcare programs requiring essential prescription medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/7/26 |